Scribe Therapeutics to Unveil Latest Preclinical Data on Proprietary CRISPR Epigenetic Silencing Technology for LDL-C Lowering at the 2025 EAS Congress
ALAMEDA, Calif.--(BUSINESS WIRE)--Scribe Therapeutics Inc. (Scribe), a genetic medicines company unlocking the potential of CRISPR to transform human health, today announced a late-breaking oral presentation at the 93rd European Atherosclerosis Society (EAS) Congress taking place between May 4-7, 2025, at the Scottish Event Campus in Glasgow, United Kingdom.
Aarif Khakoo, M.D., M.B.A., Chief Scientific Officer and Head of Research and Development at Scribe, will present the company's latest data on the application of its cutting-edge CRISPR-based epigenetic silencer at therapeutically relevant doses for the potent, durable, and safe reduction of low-density lipoprotein cholesterol (LDL-C) in non-human primates.
Scribe's iterative engineering and improvement of its epigenetic silencing technology, called the Epigenetic Long-Term X-Repressor (ELXR), is guided by its CRISPR by Design™ approach to create best-in-class in vivo genetic medicines that can transform the standard of care for broad patient populations, starting with cardiometabolic disease.
The presentation details are listed below and in the EAS Congress program.
Title: Potent, Durable, and Safe LDLc Reduction in Non-Human Primates with a Novel CRISPR-based Epigenetic Silencer at Therapeutically Relevant Doses
Session title: Late Breaker Session: Basic Science
Date:
Time: 4:00 - 4:15 p.m. BST
Location: William Harvey Hall
About Scribe Therapeutics
Scribe Therapeutics is revolutionizing medicine by developing optimized in vivo CRISPR-based genetic medicines designed to become standard of care treatments for patients suffering from highly prevalent diseases, starting with cardiometabolic disease. The company is on a mission to build the first CRISPR-based therapeutics that are effective and safe enough to transform everyone's lifetime risk for disease. Scribe's CRISPR by Design™ approach engineers bacterial immune systems into a premier suite of genome and epigenome editing tools built for unique molecular advantages in activity, specificity, and deliverability, enabling the creation of therapies with a broader therapeutic window and safe for use as a preventative treatment. The company's lead candidate, STX-1150, is a novel liver-targeted therapy designed to epigenetically silence the PCSK9 gene, resulting in significant and durable reduction of LDL-C levels. To broaden and accelerate the impact of its engineered CRISPR technologies for patients, Scribe has formed strategic collaborations with world-leading pharmaceutical companies including Sanofi and Eli Lilly. Co-founded by Nobel Prize winner Jennifer Doudna and backed by leading life sciences investors, Scribe is engineering the future of genetic medicine. To learn more, visit www.scribetx.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indianapolis Star
3 hours ago
- Indianapolis Star
FDA: More cucumbers, ready-to-eat products recalled in growing salmonella outbreak
A Maryland food company has recalled specific salsa and cucumber products because they were made with cucumbers that are possibly contaminated with salmonella. TGD Cuts, LLC of Jessup, Maryland, is recalling some tub and tray products because they contained cucumbers from Boynton Beach, Florida-based Bedner Growers Inc., which have been linked to a salmonella outbreak. TGD Cuts distributed the affected products, which included salsas, sliced cucumbers and cucumber spears, to retail and foodservice locations in Maryland, Virginia, Pennsylvania, New Jersey, and North Carolina, according to the Food and Drug Administration (FDA). The products had use-by dates ranging from May 20 to May 28 and are unlikely to be in stores or being used. No illnesses have been reported in connection with the products, the FDA said. Egg recall: Brown eggs sold at some Walmart stores have salmonella risk The initial May 19 recall involved cucumbers sold directly to consumers at Bednar's Farm Fresh Market, according to notices published May 19 by the Centers for Disease Control and Prevention (CDC) and the FDA. Subsequent recalls have been announced by grocers such as Harris Teeter, Kroger and Walmart for repackaged cucumbers for resale under different brand names or those used in ready-to-eat products, including vegetable trays and salads. The cucumbers, distributed by Fresh Start Produce Sales of Delray, Florida, also led to Target recalling individual cucumbers on May 30, specifically cucumber two-packs and various prepared foods products. In addition to the growing cucumber-related recall, other products have been recalled recently for potential salmonella contamination. The FDA on May 28 upgraded a recall of tomatoes distributed in three southern states to a Class I recall, meaning consumption of the food could cause serious health complications or lead to death. Then, on June 6, the CDC and FDA linked brown eggs sold in nine states – including at some Walmart stores – to an ongoing Salmonella Enteritidis outbreak, in which 79 people have been sickened and at least 21 hospitalized. Customers who purchased any products from TGD Cuts should get rid of them or return them for a full refund. Here is the list of products recalled due to a possible salmonella risk. Salmonella poisoning causes about 1.35 million illnesses, 26,500 hospitalizations, and 420 deaths each year in the U.S., according to the CDC and FDA. Symptoms, which include diarrhea, fever and stomach cramps, will usually occur six hours to six days after exposure and may last up to seven days. Symptoms from severe infections may include aches, headaches, elevated fever, lethargy, rashes, and blood in urine or stool. Mike Snider is a reporter on USA TODAY's Trending team. You can follow him on Threads, Bluesky, X and email him at mikegsnider & @ & @mikesnider & msnider@
Yahoo
4 hours ago
- Yahoo
GOP's health care plan: We're all going to die, so whatever
If death and taxes are the only certainties, Joni Ernst is here to cut one and fast-track the other. 'We all are going to die," she said. You might think that's a line from a nihilistic French play. Or something a teenage goth said in Hot Topic. Or an epiphany from your stoner college roommate after he watched Interstellar at 3 a.m. But that was actually the Iowa Senator's God-honest response to concerns that slashing Medicaid to achieve President Trump's 'Big Beautiful Bill' would lead to more preventable deaths. The full exchange at a May 30 town hall included one audience member shouting at the stage, 'People will die!' And Ernst responding, 'People are not — well, we all are going to die, so for heaven's sake.' That's not a health care policy — that's a horoscope for the terminally screwed. As you can imagine, the internet didn't love it, because losing your health should not trigger the equivalent of a shrug emoji from someone elected to serve the public good. But rather than walking it back, Ernst leaned in, filming a mock apology in a graveyard because nothing says, 'I care about your future,' like filming next to people who don't have one. Opinion: Nurses are drowning while Braun ignores Indiana's health care crisis Ernst's comments aren't just philosophical musings. She's justifying policy choices that cause real harm. If passed, this bill would, according to the Congressional Budget Office, remove health coverage for up to 7.6 million Americans. That's not just 'we all die someday' territory. That's 'some people will die soon and needlessly.' What makes this even more galling is that the people pushing these cuts have access to high-quality, taxpayer-subsidized healthcare. Congress gets the AAA, platinum, concierge-level government plan. Meanwhile, millions of Americans are told to try their luck with essential oils or YouTube acupuncture tutorials. Honestly, it felt more like performance art than policy: 'Sorry about your grandma getting kicked out of her assisted living facility. Please enjoy this scenic view of her future! LOL!' We're not asking you to defeat death, senator. Death is both inevitable and bipartisan. But there is a broad chasm between dying peacefully at 85 and dying in your 40's because your Medicaid plan disappeared and your GoFundMe didn't meet its goal. Fundamentally, governing is about priorities. A budget is a moral document. When a lawmaker tells you 'we're all going to die' in response to a policy choice, they're telling you 'I've made peace with your suffering as collateral damage.' And if a U.S. Senator can stand in a cemetery and joke about it, you have to wonder — who do our federal legislators think those graves are for? Opinion: Indiana DCS cut foster care in half — and now claims children are safer This isn't just about one comment or one bill. It's about a mindset that treats healthcare as a luxury rather than a right. If death is inevitable, then access to healthcare you can afford is what helps determine how long you have, how comfortably you live, and whether you get to watch your kids grow up. Healthcare isn't about escaping death. It's about dignity and quality of life while we are here. Ernst got one thing right: death will come for us all. But leadership, real leadership, is about helping people live as long and as well as they can before that day comes. You want to make jokes, Senator? Fine. But if your punchline is 'You're all going to die anyway,' don't be surprised when your constituents realize the joke's on them. Kristin Brey is the "My Take" columnist for the Milwaukee Journal Sentinel. This article originally appeared on Milwaukee Journal Sentinel: Joni Ernst films graveyard video after telling sick people "we all die" | Opinion
Washington Post
4 hours ago
- Washington Post
The NASA science missions that would be axed in Trump's 2026 budget
President Donald Trump's fiscal 2026 budget request, if approved by Congress, would kill many of NASA's plans for robotic exploration of the solar system. Gone, too, would be multiple space-based missions to study Earth, the sun and the rest of the universe. Among the planets that would get less attention are Venus, Mars and Jupiter. But the planet facing the biggest drop in scrutiny from space is our own. The Trump budget proposal calls for reducing Earth science funding by 53 percent.
